European Biomanufacturing Summit

The European Biomanufacturing Summit, organized by the Generis Group, is a premier event tailored for biopharmaceutical and biomanufacturing executives. Scheduled for October 22-23, 2025, at the Maritim Hotel Düsseldorf in Germany, the summit aims to provide insights into current trends in biotechnology and pharmaceuticals, including advances in cell and gene therapy, and CMC pharmaceutical development. ​

The summit's agenda encompasses strategic discussions on biotechnological developments, best practices in manufacturing, drug delivery, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics. What distinguishes this conference is its curated program featuring C-Suite and VP-level speakers, offering attendees a platform to learn about the latest trends in European biotechnology and global biomanufacturing insights. ​

Notable speakers at the 2025 summit include:​

• Joydeep Ganguly, SVP, Corporate Operations at Gilead Sciences​
• Hani Friedman Bouganim, EVP, Manufacturing, Quality, and Supply Chain at Servier​
• Hans-Peter Grau, SVP and Head, Global Biotech Manufacturing at Merck KGaA​
• Sarah Dayre, VP, Supply, EMEA at AstraZeneca​
• Sean Gaskell, Ph.D., SVP, Global Drug Substance Operations at Moderna​
• Laura O'Brien, SVP and Head, Global Manufacturing at CSL

The summit is expected to attract over 150 senior-level executives from leading biopharmaceutical companies, providing ample networking opportunities.